Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines
- PMID: 8018328
- DOI: 10.1001/archotol.1994.01880310054010
Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines
Abstract
Objective: According to some clinical reports, DNA aneuploidy of squamous cell carcinomas is related to a more favorable response to radiotherapy than DNA diploidy, but it is not known whether this depends on differences in intrinsic cellular radiation sensitivity or on other factors involved during the course of radiotherapy.
Design: Using flow cytometry, we analyzed 30 newly established squamous carcinoma cell lines derived from head and neck carcinoma, and compared the nuclear DNA content with the inherent radiosensitivity and with the average doubling time determined from the in vitro growth curves.
Results: The nuclear DNA content expressed as the ratio between the Go/G1 peak of the cell line and the peak formed by chicken red blood cells varied from 3.13 to 6.41. The DNA content of cells obtained from nonmalignant lesions by fine-needle aspiration biopsy was from 2.66 to 2.80. No correlation was found between the nuclear DNA content and the inherent radiosensitivity of the carcinoma cells.
Conclusions: The result suggests that the intrinsic cellular radiosensitivity of carcinomas does not increase in parallel with an increasing nuclear DNA content. Nor does the in vitro proliferation rate associate with either the nuclear DNA content or inherent radiosensitivity.
Similar articles
-
Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):661-71. doi: 10.1016/0360-3016(94)90552-5. Int J Radiat Oncol Biol Phys. 1994. PMID: 7913703 Clinical Trial.
-
Tumor cell DNA content and radiation response in head and neck squamous cell carcinoma.Acta Oncol. 1995;34(7):977-8. doi: 10.3109/02841869509127220. Acta Oncol. 1995. PMID: 7492396 No abstract available.
-
Proliferative capacity in head and neck cancer.Head Neck. 2001 Jun;23(6):484-91. doi: 10.1002/hed.1064. Head Neck. 2001. PMID: 11360311
-
Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck.Semin Oncol. 1994 Jun;21(3):330-9. Semin Oncol. 1994. PMID: 8209264 Review. No abstract available.
-
DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma.Virchows Arch. 2002 Dec;441(6):541-50. doi: 10.1007/s00428-002-0729-3. Epub 2002 Nov 5. Virchows Arch. 2002. PMID: 12461610 Review.
Cited by
-
Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers.Nat Commun. 2016 Feb 2;7:10438. doi: 10.1038/ncomms10438. Nat Commun. 2016. PMID: 26832959 Free PMC article.
-
DNA ploidy and protein synthesis in squamous cell carcinoma cell lines of the head and neck.J Cancer Res Clin Oncol. 1997;123(1):39-44. doi: 10.1007/BF01212613. J Cancer Res Clin Oncol. 1997. PMID: 8996539 Free PMC article.
-
The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.Br J Cancer. 1999 Jul;80(9):1400-4. doi: 10.1038/sj.bjc.6690535. Br J Cancer. 1999. PMID: 10424742 Free PMC article.
-
Broccoli extract improves chemotherapeutic drug efficacy against head-neck squamous cell carcinomas.Med Oncol. 2018 Aug 4;35(9):124. doi: 10.1007/s12032-018-1186-4. Med Oncol. 2018. PMID: 30078069
-
Differential proliferation dependence of alpha and beta damage in X-irradiated Chinese hamster cells.Strahlenther Onkol. 1999 May;175(5):239-44. doi: 10.1007/BF02742402. Strahlenther Onkol. 1999. PMID: 10356614
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical